Tanja Herrmann

Tanja Herrmann has over 14 years of work experience in the biotechnology industry. Tanja currently holds the position of Director Project Management at Cimeio Therapeutics, a role they have held since 2021. Prior to this, they worked at Pieris Pharmaceuticals from 2017 to 2021, where they were the Senior Associate Director /Group Leader Selection Technologies and Project Leader Discovery. From 2014 to 2017, they worked at Medigene AG as a Team Leader and Senior Scientist. From 2007 to 2014, they were employed at MorphoSys AG as a Project Team Leader and Scientist. Her career began in 2006 when they were a Postdoctoral Researcher at Eberhard Karls University Tübingen.

Tanja Herrmann's education history includes a Doctor of Philosophy (Ph.D.) in Biology (Immunology) from Eberhard Karls University Tübingen, which they obtained between 2003 and 2006. Tanja also earned a Diploma in Biology from the same university between 1996 and 2003. In addition, they completed a research internship at Cambridge Antibody Technology (MedImmune) in 2003. Tanja also had research internships at the Institute of Tropical Medicine, Tübingen, the University of Guelph, Ontario, Canada, and the Max-Planck-Institute for Biology, Tübingen between 2000 and 2001, 1999 and 2000, and 1999, respectively.